G. Walmsley Graham - 11 Jun 2021 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)

Reporting relationship: Director
Issuer ticker: ALXO
Reported as of: 11 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 15 Jun 2021, 19:03:39 UTC
Prior SEC filing: 10 Jun 2021
Next SEC filing: 03 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Peter Garcia, by power of attorney

Key filing fact

G. Walmsley Graham filed Form 4 for ALX ONCOLOGY HOLDINGS INC (ALXO) on 15 Jun 2021.

Key facts

This page summarizes G. Walmsley Graham's Form 4 filing for ALX ONCOLOGY HOLDINGS INC (ALXO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 15 Jun 2021, 19:03.

Change

Previous filing in this sequence was filed on 10 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ALXO transaction Derivative

Stock option (right to buy)

Award

Transaction value: $0
Shares: +12,004
Change %
Price: $0.000000
Shares after: 12,004
Date: 11 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,004
Exercise price: $59.66
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares subject to the option vest in 12 equal monthly installments on the same day of the month as the grant date, or if earlier, the day immediately before the day of the next annual meeting of stockholders.